Hyperthyroidism Can Precipitate Peak‐Dose Levodopa‐Induced Dyskinesia in Parkinson's Disease

Documenti analoghi

• Amantadine Can Treat Blepharospasm in Levodopa Peak‐Dose Dyskinesia
  di: Francisco de Assis Aquino Gondim, et al.
  Pubblicazione: (2025)
• Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial
  di: Angelo Antonini, et al.
  Pubblicazione: (2025)
• Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease
  di: Maria Teresa Pellecchia, et al.
  Pubblicazione: (2025)
• Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study
  di: Diego Santos‐García, et al.
  Pubblicazione: (2024)
• Levodopa‐Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study
  di: Alfonso Fasano, et al.
  Pubblicazione: (2025)